Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl FR, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki JR, Lohse AW, Schrader J. Benten D, et al. Among authors: schrader j. Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12. Mol Cancer Res. 2018. PMID: 29330294
Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.
Fraedrich K, Schrader J, Ittrich H, Keller G, Gontarewicz A, Matzat V, Kromminga A, Pace A, Moll J, Bläker M, Lohse AW, Hörsch D, Brümmendorf TH, Benten D. Fraedrich K, et al. Among authors: schrader j. Clin Cancer Res. 2012 Sep 1;18(17):4621-32. doi: 10.1158/1078-0432.CCR-11-2968. Epub 2012 Jul 2. Clin Cancer Res. 2012. PMID: 22753592
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug S, Kegel T, Gress TM, Rinke A, Apostolidis L, Jann H, König A, Hörsch D, Schrader J, Ettrich TJ, Richter M, Steighardt J, Michl P. Krug S, et al. Among authors: schrader j. BMC Cancer. 2021 Nov 12;21(1):1206. doi: 10.1186/s12885-021-08900-7. BMC Cancer. 2021. PMID: 34772353 Free PMC article.
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J. Fraune C, et al. Among authors: schrader j. Endocr Pathol. 2020 Jun;31(2):182-189. doi: 10.1007/s12022-020-09612-7. Endocr Pathol. 2020. PMID: 32144630 Free PMC article.
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
Matrood S, Apostolidis L, Schrader J, Krug S, Lahner H, Ramaswamy A, Librizzi D, Kender Z, Kröcher A, Kreutzfeldt S, Gress TM, Rinke A. Matrood S, et al. Among authors: schrader j. Front Endocrinol (Lausanne). 2021 Oct 6;12:709256. doi: 10.3389/fendo.2021.709256. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34690926 Free PMC article.
[Endoscopic Resection for GEP-NET].
Ehlken H, Younis F, Wolter S, Schrader J. Ehlken H, et al. Among authors: schrader j. Zentralbl Chir. 2022 Jun;147(3):256-263. doi: 10.1055/a-1829-7370. Epub 2022 Jun 15. Zentralbl Chir. 2022. PMID: 35705087 German.
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.
Schmitz RL, Weissbach J, Kleilein J, Bell J, Hüttelmaier S, Viol F, Clauditz T, Grabowski P, Laumen H, Rosendahl J, Michl P, Schrader J, Krug S. Schmitz RL, et al. Among authors: schrader j. Cells. 2021 Jun 6;10(6):1408. doi: 10.3390/cells10061408. Cells. 2021. PMID: 34204116 Free PMC article.
917 results